The Business of Cures
I’d feel better if I knew some in our brilliant science community were working hard on ways to taper patients, if just the most highly motivated, off the medications with a reduced risk of return to heroin.
Read More
Author: C. Scott McMillin
When Alcohol Pays for Research
After all, you can’t afford to stop selling it. That’s not how you get promoted. What you need is science that seems to confirm your biases.
Read More
In the News: Update on Prince
The real solution would have been for Prince to have received treatment for his drug problem, which by this time was a far bigger issue than his somatic pain.
Read More
Politics and Pharmacy
A number of experts pointed out the risks associated with a dramatic increase in opioid prescribing. They were ignored in favor of others who downplayed those risks.
Read More
In the News: The FDA in Action?
It’s a move that helps bring the FDA on board with the CDC, instead of simply reviewing and approving new pharmaceutical opioids for the marketplace.
Read More